Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo
Cited by 21
Related Papers
miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
|International Journal of Oncology|2014|48
Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance
|Cancer Cell International|2020|43
Effects of karanjin on cell cycle arrest and apoptosis in human A549, HepG2 and HL-60 cancer cells
|Biological Research|2015|39